Accuray | ARAY - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Abbott USD 52.06B 69M 2026-03
Accuray USD 53.42M 8.45M 2025-12
AngioDynamics USD 176.33M 2.52M 2025-09
Artivion USD 445.58M 4.88M 2026-06
AtriCure USD 516.43M 24.74M 2026-06
Boston Scientific USD 24.93B 934M 2026-06
Edwards Lifesciences USD 10.62B 290.5M 2026-06
Inogen USD 197.18M 2.32M 2025-09
Mesa Laboratories USD 186.69M 8.22M 2025-12
Orthofix International USD 429.18M 6.01M 2026-06
Tandem Diabetes Care USD 130.39M 2.02M 2026-06
Trinity Biotech USD -71.98M 17.26M 2025-12